SARDOCOR

Adhesive plasters for medical purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; cardiovascular agents for medical purposes; cardiovascular medicines; cells for medical or clinical use; cells for medical purposes; chemical reagents for medical or veterinary purposes for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; diagnostic preparations for medical purposes for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; dietary supplements for humans; dietary supplements for pets in the form of treats; dietetic foods adapted for medical purposes; disinfectants; food for babies; fungicides; gene therapy products, namely, genetically engineered tissues for transplant purposes; herbicides; medicinal preparations for regenerative and reparative therapies; nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; preparations for destroying vermin; sanitary preparations for medical use; sanitary preparations for veterinary use; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants comprised of living tissues; synthetic peptides for pharmaceutical purposes; synthetic peptides for the treatment of respiratory conditions; veterinary preparations for regenerative and reparative therapies; pharmaceutical preparations for the treatment of heart disorders and systemic diseases associated with cardiac pathology; drugs for the prevention and treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; living cells for medical purpose

Bacteriological research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biological research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biomedical research services for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; biotechnology research for use in gene and cell therapies for cardiovascular diseases and systemic diseases associated with cardiac pathology; chemical research for use in gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; conducting clinical trials; conducting clinical trials for others; conducting early evaluations in the field of new pharmaceuticals for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; development of biopharmaceutical products and medicine for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; drug discovery services; engineering services, particularly technical project planning and design engineering of lines for the processing of web products; industrial research in the field of regenerative and reparative therapies; medical and pharmaceutical research services in the field of gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; medical laboratory services; pharmaceutical research services; pharmaceutical drug development services for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; product evaluation and analysis; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development and consultation related thereto in the field of technique; research and development of new products for others; research and development of vaccines and medicines for gene and cell therapies for the treatment of cardiovascular diseases and systemic diseases associated with cardiac pathology; scientific research in the field of gene therapy; stem cell research services; technical research in the field of pharmaceutical studies; technology research in the field of regenerative and therapies

Blood bank services; healthcare services; human tissue bank services; medical care services; medical services; medical testing and evaluation; organ and tissue bank services; stem cell therapy services; medical services and consultancy services relating to cardiovascular diseases